icometrix, a global expert in brain imaging artificial intelligence solutions, acquired $18 million in a funding round led by Forestay Capital, Optum Ventures, and existing investor Capricorn Venture Partners.
icometrix’s CE-marked and FDA-cleared icobrain software is designed to extract clinically meaningful information from brain MRI and CT scans of patients with neurological disorders including multiple sclerosis, Alzheimer’s disease, dementia, and traumatic brain injuries. According to the company, the icobrain AI solutions are used in 100 hospitals and imaging center networks worldwide, and in clinical studies by four out of the top five pharmaceutical companies.